Leading thinkers and senior executives from companies and government
organizations will gather for 3rd Annual Personalized Medicine event
produced by Burrill Life Sciences Media Group
SAN FRANCISCO, Sept. 13 /PRNewswire/ -- In the foreseeable future a trip to the doctor's office will be a radically different experience to what it is today. Armed with our complete genetic profile information about predisposition to disease, the appropriate remedial therapies, even what foods to eat will be part of the doctor's advice. While we can see the future of health care, we are still a tantalizing long way away from embracing it. There are many scientific, legal, ethical, regulatory and policy challenges that have to be addressed before personalized medicine becomes a reality in 21st century medicine.
The 3rd Burrill Personalized Medicine Meeting (San Francisco, November 12-13, 2007), hosted by Burrill Life Sciences Media Group, a joint venture of Nielsen Business Media and Burrill & Company, provides a "window" into these new realities with detailed discussions and analysis on the whole spectrum of personalized medicine -- from prediction to prevention and how they will have a major impact on the delivery of health care.
Some of the leading thinkers and senior executives from companies and government organizations will be participating in this event. Sessions include:
-- Personalized Medicine in the Clinic
-- How Science and Technology is Accelerating the Pace of Biomarker
-- Targeted Treatments vs. The "one size fits all" Blockbuster
-- Pharmacogenomics comes of Age
-- The increasing role of Diagnostics in Personalized Medicine
-- Patient-centric Medicine -- Personalized Medicine from the Patient's
Point of View
-- The Regulatory Environment: The FDA's Perspective
The Burrill Personalized Medicine Meeting has established itself as a
"must attend" eve
|SOURCE Burrill Life Sciences Media Group|
Copyright©2007 PR Newswire.
All rights reserved